These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25259806)

  • 21. Is ciprofloxacin safe in patients with solitary kidney and upper urinary tract infection?
    Gluhovschi G; Gadalean F; Gluhovschi C; Velciov S; Petrica L; Bob F; Bozdog G; Kaycsa A
    Biomed Pharmacother; 2016 Dec; 84():366-372. PubMed ID: 27668536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease.
    Abe M; Suzuki H; Okada K; Maruyama N; Inoshita A; Baba S; Takashima H; Soma M
    Heart Vessels; 2013 Jul; 28(4):442-52. PubMed ID: 22618635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
    Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
    Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.
    Fujita Y; Doi Y; Hamano T; Hatazaki M; Umayahara Y; Isaka Y; Tsubakihara Y
    Sci Rep; 2019 Oct; 9(1):14871. PubMed ID: 31619722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury in geriatric patients with urinary tract infection treated by colistin.
    Shavit L; Manilov R; Wiener-Well Y; Algur N; Slotki I
    Clin Nephrol; 2013 Dec; 80(6):405-16. PubMed ID: 24120670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and impact of proximal fixation on acute and chronic renal dysfunction after endovascular aortic aneurysm repair using glomerular filtration rate criteria.
    Pisimisis GT; Bechara CF; Barshes NR; Lin PH; Lai WS; Kougias P
    Ann Vasc Surg; 2013 Jan; 27(1):16-22. PubMed ID: 23088805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daily variability in serum levels of calciprotein particles and their association with mineral metabolism parameters: A cross-sectional pilot study.
    Yamada H; Kuro-O M; Ishikawa SE; Funazaki S; Kusaka I; Kakei M; Hara K
    Nephrology (Carlton); 2018 Mar; 23(3):226-230. PubMed ID: 28052525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validating the association between plasma tumour necrosis factor receptor 1 levels and the presence of renal injury and functional decline in patients with Type 2 diabetes.
    Doody A; Jackson S; Elliott JA; Canavan RJ; Godson C; Slattery D; Twomey PJ; McKenna MJ; le Roux CW; Docherty NG
    J Diabetes Complications; 2018 Jan; 32(1):95-99. PubMed ID: 29122448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study.
    Kittiskulnam P; Thokanit NS; Katavetin P; Susanthitaphong P; Srisawat N; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    PLoS One; 2018; 13(5):e0196332. PubMed ID: 29742114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin associated lactic acidosis (MALA): clinical profiling and management.
    Moioli A; Maresca B; Manzione A; Napoletano AM; Coclite D; Pirozzi N; Punzo G; Menè P
    J Nephrol; 2016 Dec; 29(6):783-789. PubMed ID: 26800971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40-week extension of the GUARD randomized study.
    Han SY; Yoon SA; Han BG; Kim SG; Jo YI; Jeong KH; Oh KH; Park HC; Park SH; Kang SW; Na KR; Kang SW; Kim NH; Jang Y; Kim B; Shin S; Cha DR
    Diabetes Obes Metab; 2018 Feb; 20(2):292-300. PubMed ID: 28719008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease.
    Yokota K; Fukuda M; Matsui Y; Hoshide S; Shimada K; Kario K
    Hypertens Res; 2013 Feb; 36(2):151-7. PubMed ID: 23013884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes.
    Scheen AJ
    Diabetes Metab; 2019 Apr; 45(2):110-121. PubMed ID: 30477733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some specificities in the management of hyperglycemia in patients with diabetic kidney disease.
    Dragović T; Marinković D; Kiković S; Pejović J; Hajduković Z
    Vojnosanit Pregl; 2016 Sep; 73(9):857-63. PubMed ID: 29320619
    [No Abstract]   [Full Text] [Related]  

  • 36. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM; Bondor CI; Kacso G
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorophores advanced glycation end products (AGEs)-to-NADH ratio is predictor for diabetic chronic kidney and cardiovascular disease.
    Ciobanu DM; Olar LE; Stefan R; Veresiu IA; Bala CG; Mircea PA; Roman G
    J Diabetes Complications; 2015; 29(7):893-7. PubMed ID: 26169772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenestrated-branched endovascular aortic repair in patients with chronic kidney disease.
    Khoury MK; Timaran DE; Soto-Gonzalez M; Timaran CH
    J Vasc Surg; 2020 Jul; 72(1):66-72. PubMed ID: 32063447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum bilirubin level and its impact on the progression of chronic kidney disease.
    Uludag K; Oguzhan N; Arıkan T; Boz G
    Int Urol Nephrol; 2018 Sep; 50(9):1695-1701. PubMed ID: 29946817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.